Closed loop systems, stem cells, smart insulin, and more!
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
35 readers recommended
Today, Lilly/BI announced first-ever news in diabetes: a major clinical trial on Jardiance , an SGLT-2 inhibitor pill for type 2 diabetes, has been proven to improve...
12 readers recommended
Praluent now approved for two specific patient populations. How this drug has the future potential to make a big impact on people with diabetes.
13 readers recommended
And “potentially transformative” advances coming for type 1 diabetes.
12 readers recommended
Zosano Pharma is making early progress with an innovative patch-based glucagon delivery system for severe hypoglycemia, recently announcing that it has completed...
23 readers recommended
Currently recruiting in people newly diagnosed with type 1.
The diaTribe Foundation and TCOYD Bring Together the Brightest Minds in Diabetes to Wrap Up ADA 2015
14 readers recommended
What did four diabetes experts say was the most promising future innovation in diabetes?
12 readers recommended
What a ride! This year the American Diabetes Association’s (ADA) 75 th Scientific Sessions included groundbreaking clinical trial results, the latest updates on diabetes...
30 readers recommended
One of the biggest drug highlights at the 2015 ADA Scientific Sessions was a compelling presentation by diaTribe scientific Advisory Board member Dr. John Buse on brand...
18 readers recommended
By Kelly Close Twitter Summary: @kellyclose speaks to @US_FDA in favor of PCSK9 inhibitor drug Praluent – need to bring more options to #PWD to fight against CV disease...
14 readers recommended
Kicking off this weekend, what are we most excited about for this year’s ADA?
25 readers recommended
Lilly announced that the FDA has approved its Humalog 200 units/mL KwikPen (insulin lispro) for type 1 and type 2 diabetes, making it the first concentrated mealtime...
39 readers recommended
The symptoms, who is at risk, and what every patient on SGLT-2 inhibitors can do right now.
35 readers recommended
How fast are insulin prices actually rising? Why might this be happening, and what is the impact on patients with varying levels of health care coverage?
30 readers recommended
How a new trial is testing a novel pill for blood glucose management – currently enrolling!
11 readers recommended
$300 million and counting – how much have we learned from the heart safety trials of Onglyza and Nesina?
27 readers recommended
After the rapid-acting inhaled insulin Afrezza launched this February, we have been very eager to learn more about how this new product impacts patients’ day-to-day...
18 readers recommended
Another diabetes drug that helps people lose weight?
14 readers recommended
Over seven million Americans have diabetic retinopathy – how Eylea provides another treatment for this serious complication.
Harvard Stem Cell Lab Signs Two Major Partnerships to Bring Stem Cell Therapies for Diabetes to Life
15 readers recommended
Dr. Doug Melton and colleagues at the Harvard Stem Cell Institute recently announced new partnerships with Novartis and AstraZeneca to advance stem cell research for...